{
  "context": "\n<QuestionSource url=\"https://www.wired.com/story/neuralink-implant-first-human-patient-demonstration/\">\n# Summary of Article: \"Watch Neuralink's First Human Subject Demonstrate His Brain-Computer Interface\"\n\n**Source:** WIRED  \n**Date:** March 20, 2024  \n**Author:** Emily Mullin\n\n## Key Facts and Developments:\n\n**Neuralink's First Human Subject:**\n- Noland Arbaugh, a 29-year-old man paralyzed from the shoulders down for eight years after a diving accident, was introduced as Neuralink's first human implant recipient\n- Demonstrated ability to play online chess and the video game Civilization using the brain implant\n- Showed cursor control on screen during a livestream on X (formerly Twitter)\n\n**Technology Details:**\n- The brain-computer interface decodes movement intention from brain signals\n- Initial goal: allow paralyzed people to control a cursor or keyboard using thoughts\n- Device is implanted using a surgical robot developed by Neuralink\n- Cosmetically invisible once implanted\n- Software analyzes brain signals and translates them into output commands\n\n**User Experience (from Arbaugh):**\n- Learning process involved attempting to move body parts (e.g., right hand left, right, forward, back), then imagining cursor movement became intuitive\n- Surgery described as \"super easy\" with hospital release after one day\n- No cognitive impairments reported following surgery\n- Acknowledged some issues with the device and stated \"there's a lot of work to be done\"\n\n**Timeline:**\n- Neuralink cofounded in 2016 by Elon Musk\n- FDA approval for human trial received in 2023\n- Recruitment of paralyzed participants began fall 2023\n- First human received implant (announced January 2024)\n- February 2024: Musk stated patient could control computer mouse with thoughts\n\n**Transparency Concerns (from neuroscientists and ethicists):**\n- Limited public information about the trial\n- No disclosure of number of subjects to be enrolled, trial site, or assessed outcomes\n- Not registered on ClinicalTrials.gov\n- Previous controversy over alleged treatment of animals in research (WIRED investigation detailed monkey deaths from implant testing)\n\n**Competitive Landscape:**\n- Synchron mentioned as competitor developing stent-like device inserted via jugular vein\n- Synchron implanted first subject in 2019\n- No BCI has FDA approval yet; all are experimental\n</QuestionSource>\n"
}